Analytical Data
-
基因名
RUNDC2A
- Application
-
别名
SNX29; RUNDC2A; Sorting nexin-29; RUN domain-containing protein 2A
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8TEQ0
-
表达区间
1-249 aa
-
氨基酸序列
MDEERSSMLPTMAAGPNSILFAINIDNKDLNGQSKFAPTVSDLLKESTQNVTLLKESTQGVSSVFREITASSAISILIKPEQETDPLPVVSRNVSADAKCKKERKKKKQVTNIISFDDEEDEQNSGDMFKKTPGAGESSEDNSDHSSVNIMSAFESPFGPNSNGSQSSNSWKIDSLSLNREFGYQKLDVKSIDDEDVDENEDDVYGNSSGRKHRGHSESPEKNGAHSVTQAGVQWHDLGSLQPLPPGFR
-
分子量
53.13 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RUNDC2A is an emerging protein of interest due to its potential role in cellular signaling and regulation. As a member of the RUN domain-containing protein family, RUNDC2A has been implicated in various biological processes, including cellular proliferation, apoptosis, and differentiation. Previous studies have highlighted its involvement in cancer progression and immune response, suggesting that RUNDC2A may serve as a crucial mediator in these pathways. The protein's distinctive structure, featuring a RUN domain, suggests its ability to interact with other molecular partners, thus influencing signaling cascades. Recent advancements in proteomics and molecular biology techniques have facilitated the exploration of RUNDC2A's functions and interactions at a cellular level. Understanding the mechanisms associated with RUNDC2A is vital, as it may contribute to the development of novel therapeutic strategies for diseases marked by aberrant signaling pathways, particularly in cancer biology. Consequently, research into the biochemistry and functional roles of RUNDC2A is gaining momentum, aiming to unravel its potential as a biomarker or a target for therapeutic intervention.
